本公司受邀參加華南永昌綜合證券舉辦之秋季產業趨勢暨企業論壇，說明本公司營運狀況
Agenda as filed by the company, in Chinese only.
Financial Reports
Latest Updates
Hanchor-KY (7827) Investor Conferences
Taiwanese listed companies hold investor conferences (法人說明會) to present quarterly results. Presentation decks are filed with MOPS; nothing is re-hosted here.
6
conferences
6
english decks
本公司於上市前辦理股票創新板初次上市前業績發表會，本次業績發表會將由公司經營團隊說明產業發展、財務業務狀況、未來風險、公司治理及企業社會責任、臺灣證券交易所股份有限公司董事會暨上市審議委員會要求補充揭露事項
Agenda as filed by the company, in Chinese only.
本公司自主開發腫瘤免疫融合蛋白生物藥HCB101及HCB301之研發、臨床前及臨床報告發表，受邀參加美國免疫腫瘤學會 (SITC) 舉辦之年會「SITC 40th Annual Meeting」做說明。
Agenda as filed by the company, in Chinese only.
本公司受邀參加國泰證券舉辦之法人說明會，說明本公司研發、製程、臨床與商務開發成果及未來展望。
Agenda as filed by the company, in Chinese only.
本公司受邀參加國泰證券舉辦之法人說明會，說明本公司產品研發現況及未來展望。
Agenda as filed by the company, in Chinese only.
興櫃前法人說明會，說明本公司研發進度、產品及未來展望
Agenda as filed by the company, in Chinese only.